Chemical Modification Enhances mRNA Vaccine and Therapy Effectiveness

A collaborative study by Johns Hopkins Medicine and the National Institutes of Health, published in Nature, has identified a minor chemical modification (N4-acetylcytidine) in mRNA. This alteration significantly boosts protein production by ribosomes, potentially leading to more potent mRNA vaccines and therapies. The discovery could allow for improved efficacy without increasing dosages, impacting future medical treatments.